Publications by authors named "Stefani Parmentier"

Claim this Profile
H
Hypomethylating Therapy With or Without Eltrombopag in Elderly Patients With Acute Myeloid Leukemia: Results From the Randomized, Placebo-Controlled Phase 2 DELTA Trial.
Katja Sockel, Christoph Röllig, Anke Mütherig, Martina Crysandt, Sven Zukunft, Stefani Parmentier

Am J Hematol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antithrombotic Therapy in Cancer Patients with Cardiovascular Diseases: Daily Practice Recommendations by the Hemostasis Working Party of the German Society of Hematology and Medical Oncology (DGHO) and the Society for Thrombosis and Hemostasis Research (GTH e.V.).
Stefani Parmentier, Steffen Koschmieder, Larissa Henze, Martin Griesshammer, Axel Matzdorff

Hamostaseologie· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of ruxolitinib in patients with newly-diagnosed polycythemia vera: futility analysis of the RuxoBEAT clinical trial of the GSG-MPN study group.
Steffen Koschmieder, Susanne Isfort, Dominik Wolf, Florian H Heidel, Andreas Hochhaus, Stefani Parmentier

Ann Hematol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case Report: mRNA vaccination-mediated STAT3 overactivation with agranulocytosis and clonal T-LGL expansion.
Julia R Hirsiger, Alexandar Tzankov, Ilaria Alborelli, Mike Recher, Thomas Daikeler, Stefani Parmentier

Front Immunol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sorafenib or placebo in patients with newly diagnosed acute myeloid leukaemia: long-term follow-up of the randomized controlled SORAML trial.
Christoph Röllig, Hubert Serve, Richard Noppeney, Maher Hanoun, Utz Krug, Stefani Parmentier

Leukemia· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kidney Dysfunction Is Associated with Thrombosis and Disease Severity in Myeloproliferative Neoplasms: Implications from the German Study Group for MPN Bioregistry.
Judith Gecht, Ioannis Tsoukakis, Kim Kricheldorf, Frank Stegelmann, Martine Klausmann, Stefani Parmentier

Cancers (Basel)· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decitabine treatment in 311 patients with acute myeloid leukemia: outcome and impact of mutations - a registry based analysis.
Jan M Middeke, Raphael Teipel, Christoph Röllig, Sebastian Stasik, Armin Zebisch, Stefani Parmentier

Leuk Lymphoma· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary Thromboprophylaxis in Patients with Malignancies: Daily Practice Recommendations by the Hemostasis Working Party of the German Society of Hematology and Medical Oncology (DGHO), the Society of Thrombosis and Hemostasis Research (GTH), and the Austrian Society of Hematology and Oncology (ÖGHO).
Martin Kirschner, Nicole do Ó Hartmann, Stefani Parmentier, Christina Hart, Larissa Henze

Cancers (Basel)· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reevaluation of reference values for bone marrow differential counts in 236 healthy bone marrow donors.
Stefani Parmentier, Michael Kramer, Swetlana Weller, Ulrich Schuler, Rainer Ordemann

Ann Hematol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prevalence of extramedullary acute myeloid leukemia detected by FDG-PET/CT: final results from the prospective PETAML trial.
Friedrich Stölzel, Tors Lüer, Steffen Löck, Stefani Parmentier, Friederike Kuithan

Haematologica· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-dose melphalan in elderly patients with relapsed or refractory acute myeloid leukemia: A well-tolerated and effective treatment after hypomethylating-agent failure.
Jan Stratmann, Elisabeth van Kann, Christoph Rummelt, Sebastian Koschade, Christoph Röllig, Stefani Parmentier

Leuk Res· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Follow-Up and Impact of Comorbidity before Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Relapsed or Refractory Acute Myeloid Leukemia-Lessons Learned from the Prospective BRIDGE Trial.
Jan Moritz Middeke, Regina Herbst, Stefani Parmentier, Gesine Bug, Mathias Hänel

Biol Blood Marrow Transplant· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer Screening in Patients with Idiopathic Venous Thromboembolism--a Position Paper of the German Society of Hematology and Oncology Working Group on Hemostasis.
Axel Matzdorff, Hanno Riess, Frauke Bergmann, Guido Bisping, Steffen Koschmieder, Stefani Parmentier

Oncol Res Treat· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnosis, prevention, and management of bleeding episodes in Philadelphia-negative myeloproliferative neoplasms: recommendations by the Hemostasis Working Party of the German Society of Hematology and Medical Oncology (DGHO) and the Society of Thrombosis and Hemostasis Research (GTH).
Iris Appelmann, Stephan Kreher, Stefani Parmentier, Hans-Heinrich Wolf, Guido Bisping

Ann Hematol· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mesenchymal Stromal Cells for Treatment of Acute Steroid-Refractory Graft Versus Host Disease: Clinical Responses and Long-Term Outcome.
Felix von Dalowski, Michael Kramer, Martin Wermke, Rebekka Wehner, Christoph Röllig, Stefani Parmentier

Stem Cells· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2, randomised controlled trial.
Christoph Röllig, Hubert Serve, Andreas Hüttmann, Richard Noppeney, Carsten Müller-Tidow, Stefani Parmentier

Lancet Oncol· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allele-specific PCR is a powerful tool for the detection of the MYD88 L265P mutation in diffuse large B cell lymphoma and decalcified bone marrow samples.
Annette M Staiger, M Michaela Ott, Stefani Parmentier, Andreas Rosenwald, German Ott

Br J Haematol· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myelodysplastic syndromes with a deletion 5q display a characteristic immunophenotypic profile suitable for diagnostics and response monitoring.
Uta Oelschlaegel, Theresia M Westers, Brigitte Mohr, Michael Kramer, Stefani Parmentier

Haematologica· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of rasburicase in a pregnant woman with acute lymphoblastic leukaemia and imminent tumour lysis syndrome.
Jan Moritz Middeke, Normi Bruck, Stefani Parmentier, Martin Bornhäuser, Johannes Schetelig

Ann Hematol· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bone marrow metastases by alveolar rhabdomyosarcoma in a 31-year-old patient.
Stefani Parmentier, Stephan Richter

Blood· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-dose cytarabine consolidation with or without additional amsacrine and mitoxantrone in acute myeloid leukemia: results of the prospective randomized AML2003 trial.
Markus Schaich, Stefani Parmentier, Michael Kramer, Thomas Illmer, Friedrich Stölzel

J Clin Oncol· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comment to the response to "severe pernicious anemia with distinct cytogenetic and flow cytometric aberrations mimicking myelodysplastic syndrome".
Uta Oelschlaegel, Stefani Parmentier, Uwe Platzbecker

Ann Hematol· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Severe pernicious anemia with distinct cytogenetic and flow cytometric aberrations mimicking myelodysplastic syndrome.
Stefani Parmentier, Joern Meinel, Uta Oelschlaegel, Brigitte Mohr, Gerhard Ehninger

Ann Hematol· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of dysplastic hematopoiesis: lessons from healthy bone marrow donors.
Stefani Parmentier, Johannes Schetelig, Kerstin Lorenz, Michael Kramer, Robin Ireland

Haematologica· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pseudo-Auer rods in a patient with newly diagnosed IgG myeloma.
Stefani Parmentier, Joergen Radke

Blood· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis